These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19661119)

  • 1. The effect of diabetic medications on creatine kinase-myocardial band levels in patients undergoing coronary artery bypass surgery.
    Engoren M; Zacharias A; Habib RH; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):793-6. PubMed ID: 19661119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?
    Tennyson C; Lee R; Attia R
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):1000-8. PubMed ID: 24021615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic control and coronary artery bypass: effect on short-term outcomes.
    Strahan S; Harvey RM; Campbell-Lloyd A; Beller E; Mundy J; Shah P
    Asian Cardiovasc Thorac Ann; 2013 Jun; 21(3):281-7. PubMed ID: 24570493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting.
    Bhamidipati CM; LaPar DJ; Stukenborg GJ; Morrison CC; Kern JA; Kron IL; Ailawadi G
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):543-51. PubMed ID: 21163498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of elevated creatine kinase-myocardial band on mortality after coronary artery bypass grafting surgery is time and magnitude limited.
    Engoren MC; Habib RH; Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):114-9. PubMed ID: 15982595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.
    Cuculi F; Lim CC; van Gaal W; Testa L; Westaby S; Arnold JR; Neubauer S; Banning AP
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):585-9. PubMed ID: 21908890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.
    Lazar HL; McDonnell MM; Chipkin S; Fitzgerald C; Bliss C; Cabral H
    Ann Surg; 2011 Sep; 254(3):458-63; discussion 463-4. PubMed ID: 21865944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency coronary artery bypass grafting for left main shock syndrome.
    Osawa H; Fujimatsu T
    Ann Thorac Cardiovasc Surg; 2011; 17(6):565-9. PubMed ID: 21881355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial.
    Desai SP; Henry LL; Holmes SD; Hunt SL; Martin CT; Hebsur S; Ad N
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):318-25. PubMed ID: 22137804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
    Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery.
    Forlani S; Tomai F; De Paulis R; Turani F; Colella DF; Nardi P; De Notaris S; Moscarelli M; Magliano G; Crea F; Chiariello L
    J Cardiovasc Surg (Torino); 2004 Apr; 45(2):117-22. PubMed ID: 15179345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency surgery for left main disease: with and without cardioplegic arrest.
    Tsutsumi K; Ishida O; Hashizume K; Inoue Y
    Asian Cardiovasc Thorac Ann; 2019 Mar; 27(3):157-162. PubMed ID: 30661379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.
    Muehlschlegel JD; Perry TE; Liu KY; Fox AA; Collard CD; Shernan SK; Body SC
    Anesth Analg; 2010 Nov; 111(5):1101-9. PubMed ID: 20457766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial.
    Gavard JA; Chaitman BR; Sakai S; Stocke K; Danchin N; Erhardt L; Gallo R; Chi E; Jessel A; Théroux P;
    J Thorac Cardiovasc Surg; 2003 Sep; 126(3):807-13. PubMed ID: 14502157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes and early revascularization on the need for late and repeat procedures.
    Orbach A; Halon DA; Jaffe R; Rubinshtein R; Karkabi B; Flugelman MY; Zafrir B
    Cardiovasc Diabetol; 2018 Feb; 17(1):25. PubMed ID: 29402330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
    Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
    J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we really need another biomarker to diagnose myocardial infarction after coronary artery bypass graft surgery?
    Rade JJ; Hogue CW
    Anesth Analg; 2010 Nov; 111(5):1086-7. PubMed ID: 20971957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.